Organovo Holdings, Inc. (ONVO)
NASDAQ: ONVO · Real-Time Price · USD
2.240
-0.170 (-7.05%)
At close: Mar 31, 2025, 4:00 PM
2.279
+0.038 (1.72%)
After-hours: Mar 31, 2025, 6:49 PM EDT
Organovo Holdings Employees
As of March 31, 2024, Organovo Holdings had 20 total employees, including 12 full-time and 8 part-time employees. The number of employees decreased by 4 or -16.67% compared to the previous year.
Employees
20
Change (1Y)
-4
Growth (1Y)
-16.67%
Revenue / Employee
$6,100
Profits / Employee
-$619,250
Market Cap
3.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ONVO News
- 4 days ago - Organovo Provides Business Update - GlobeNewsWire
- 6 days ago - Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company - GlobeNewsWire
- 12 days ago - Organovo Announces Reverse Stock Split - GlobeNewsWire
- 20 days ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 25 days ago - Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises - GlobeNewsWire
- 4 weeks ago - Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company - GlobeNewsWire
- 3 months ago - Organovo Announces Appointment of Norman Staskey as Chief Financial Officer - GlobeNewsWire
- 4 months ago - Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - GlobeNewsWire